The emerging role of targeted protein degradation to treat and study cancer.
Saved in:
| Title: | The emerging role of targeted protein degradation to treat and study cancer. |
|---|---|
| Authors: | Brodermann MH; Department of Haematology, UCL Cancer Institute, University College London, London, UK., Henderson EK; Department of Haematology, UCL Cancer Institute, University College London, London, UK., Sellar RS; Department of Haematology, UCL Cancer Institute, University College London, London, UK. |
| Source: | The Journal of pathology [J Pathol] 2024 Aug; Vol. 263 (4-5), pp. 403-417. Date of Electronic Publication: 2024 Jun 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38886898 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The emerging role of targeted protein degradation to treat and study cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Brodermann+MH%22">Brodermann MH</searchLink>; Department of Haematology, UCL Cancer Institute, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Henderson+EK%22">Henderson EK</searchLink>; Department of Haematology, UCL Cancer Institute, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sellar+RS%22">Sellar RS</searchLink>; Department of Haematology, UCL Cancer Institute, University College London, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220204634%22">The Journal of pathology</searchLink> [J Pathol] 2024 Aug; Vol. 263 (4-5), pp. 403-417. <i>Date of Electronic Publication: </i>2024 Jun 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+And+Sons%22">John Wiley And Sons </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0204634 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9896 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223417%22">00223417 </searchLink><i>NLM ISO Abbreviation: </i>J Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38886898 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/path.6301 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 403 Titles: – TitleFull: The emerging role of targeted protein degradation to treat and study cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Brodermann MH – PersonEntity: Name: NameFull: Henderson EK – PersonEntity: Name: NameFull: Sellar RS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1096-9896 Numbering: – Type: volume Value: 263 – Type: issue Value: 4-5 Titles: – TitleFull: The Journal of pathology Type: main |
| ResultId | 1 |